N. Raghunand et al., Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 humanbreast carcinoma xenografts measured by P-31 magnetic resonance spectroscopy, BIOCH PHARM, 57(3), 1999, pp. 309-312
P-31 Magnetic resonance spectroscopy (MRS) was employed to investigate tumo
r pH in xenografts of drug-sensitive and drug-resistant MCF-7 human breast
carcinoma cells. Measured extracellular pH values were found to be lower th
an the intracellular pH in all three tumor types investigated. The magnitud
e of this acid-outside plasmalemmal pH gradient increased with increasing t
umor size in tumors of two drug-resistant variants of MCF-7 cells, but not
in tumors of the parent (drug-sensitive) cells. The partitioning of weak-ba
se or weak-acid drug molecules across the plasma membrane of a tumor cell i
s dependent upon the acid-dissociation constant (pK(a)) of the drug as well
as the plasmalemmal pH gradient. A large acid-outside pH gradient, such as
those seen in MCF-7 xenografts, can exert. a protective effect on the cell
from weak-base drugs such as anthracyclines and Vinca alkaloids, which hav
e pk(a) values of 7.5 to 9.5. The possibility of enhancing the therapeutic
efficacy of weak-base drugs by dietary or metabolic manipulation of the ext
racellular pH, in order to reduce or reverse the plasmalemmal pH gradient,
deserves investigation. (C) 1998 Elsevier Science Inc.